Download PDF
Semin Respir Crit Care Med 2024; 45(05): 548-559
DOI: 10.1055/s-0044-1785679
Review Article

Impact of Marijuana Use on Lung Health

Joanne M. Bando
1   Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
,
Donald P. Tashkin
1   Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
,
Igor Z. Barjaktarevic
1   Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

The widespread use of marijuana in the context of increasing legalization has both short- and long-term health implications. Although various modes of marijuana use—smoked, vaped, or ingested—may lead to a wide scope of potential systemic effects, we focus here on inhalational use of marijuana as the most common mode with the lung as the organ that is most directly exposed to its effects. Smoked marijuana has been associated with symptoms of chronic bronchitis and histopathologic changes in airway epithelium, but without consistent evidence of long-term decline in pulmonary function. Its role in immunomodulation, both for risk of infection and protection against a hyperinflammatory host response to infection, has been suggested in animal models and in vitro without conclusive extrapolation to humans. Marijuana smoke contains carcinogens like those found in tobacco, raising concern about its role in lung cancer, but evidence is mixed and made challenging by concurrent tobacco use. Vaping may offer a potential degree of harm reduction when compared with smoking marijuana with reduction of exposure to several toxins, including carbon monoxide, and reduction in chronic respiratory symptoms. However, these potential benefits are counterbalanced by risks including vaping-associated lung injury, potentially more intense drug exposure, and other yet not well-understood toxicities. As more states legalize marijuana and the federal government considers changing this from a Schedule I to a Schedule III controlled substance, we anticipate an increase in prospective medical studies concerning the risks related to marijuana use. This review is based on currently available data concerning the impact of inhaled marijuana on lung health.

Keywords

marijuana - cannabis - lung health


Publication History

Article published online:
05 July 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Touw M. The religious and medicinal uses of Cannabis in China, India and Tibet. J Psychoactive Drugs 1981; 13 (01) 23-34
    CrossrefPubMedGoogle Scholar
  • 2 Brill H. Marihuana: the first twelve thousand years. J Psychoactive Drugs 1981; 13 (04) 397-398
    CrossrefPubMedGoogle Scholar
  • 3 Atakan Z. Cannabis, a complex plant: different compounds and different effects on individuals. Ther Adv Psychopharmacol 2012; 2 (06) 241-254
    CrossrefPubMedGoogle Scholar
  • 4 Stuyt E. The problem with the current high potency THC marijuana from the perspective of an addiction psychiatrist. Mo Med 2018; 115 (06) 482-486
    PubMedGoogle Scholar
  • 5 Turner AR, Patel P, Agrawal S. Marijuana. StatPearls Publishing; Treasure Island (FL): , Jan 2024
    Google Scholar
  • 6 NIDA. How does marijuana produce its effects?. Accessed April 13, 2021 at: www.nida.nih.gov 2021
    PubMedGoogle Scholar
  • 7 Tashkin DP, Shapiro BJ, Frank IM. Acute effects of smoked marijuana and oral delta9-tetrahydrocannabinol on specific airway conductance in asthmatic subjects. Am Rev Respir Dis 1974; 109 (04) 420-428
    PubMedGoogle Scholar
  • 8 Tashkin DP, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men. N Engl J Med 1973; 289 (07) 336-341
    CrossrefPubMedGoogle Scholar
  • 9 Kilmer B, Caulkins J, Pacula R, Reuter P. Bringing perspective to illicit markets: estimating the size of the U.S. marijuana market. Drug Alcohol Depend 2011; 119 (1-2) 153-160
    CrossrefPubMedGoogle Scholar
  • 10 Caulkins JP, Kilmer B. The US as an example of how not to legalize marijuana?. Addiction 2016; 111 (12) 2095-2096
    CrossrefPubMedGoogle Scholar
  • 11 National Conference of State Legislatures. State Medical Cannabis Laws Report. www.NCLS.org . June 2023
    PubMedGoogle Scholar
  • 12 Werner-Simon J, Wilson E. Maryland's New Recreational Marijuana Law: Suggestions For Maryland's Policymakers & Employers. Maryland State Bar Association; 2023
    Google Scholar
  • 13 Werner-Simon J. Three Degrees of Legalization Show Cannabis' Prevalence.
    PubMedGoogle Scholar
  • 14 Jones CM, Clayton HB, Deputy NP. et al. Prescription opioid misuse and use of alcohol and other substances among high school students—youth risk behavior survey, United States, 2019. MMWR Suppl 2020; 69 (01) 38-46
    CrossrefPubMedGoogle Scholar
  • 15 National Survey on Drug Use and Health (NSDUH). Results from the 2022 NSDUH: Detailed Tables. Substance Abuse and Mental Health Services Administration, November, 2023
    PubMed
  • 16 Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health. U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration, November 2023; Publication Number PEP23-07-01-006
    PubMed
  • 17 Rodgman A. . PTA. The Chemical Components of Tobacco and Tobacco Smoke. CRC Press. 2013
    Google Scholar
  • 18 Graves BM, Johnson TJ, Nishida RT. et al. Comprehensive characterization of mainstream marijuana and tobacco smoke. Sci Rep 2020; 10 (01) 7160
    CrossrefPubMedGoogle Scholar
  • 19 Moir D, Rickert WS, Levasseur G. et al. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol 2008; 21 (02) 494-502
    CrossrefPubMedGoogle Scholar
  • 20 DeMarini DM. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 2004; 567 (2-3): 447-474
    CrossrefPubMedGoogle Scholar
  • 21 Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med 1988; 318 (06) 347-351
    CrossrefPubMedGoogle Scholar
  • 22 Tashkin DP, Baldwin GC, Sarafian T, Dubinett S, Roth MD. Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol 2002; 42 (S1): 71S-81S
    CrossrefPubMedGoogle Scholar
  • 23 Klein TW, Newton C, Friedman H. Cannabinoid receptors and immunity. Immunol Today 1998; 19 (08) 373-381
    CrossrefPubMedGoogle Scholar
  • 24 Roth MD, Baldwin GC, Tashkin DP. Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Chem Phys Lipids 2002; 121 (1-2): 229-239
    CrossrefPubMedGoogle Scholar
  • 25 Cabral GA, Lockmuller JC, Mishkin EM. Delta 9-tetrahydrocannabinol decreases alpha/beta interferon response to herpes simplex virus type 2 in the B6C3F1 mouse. Proc Soc Exp Biol Med 1986; 181 (02) 305-311
    CrossrefPubMedGoogle Scholar
  • 26 Roth MD, Whittaker K, Salehi K, Tashkin DP, Baldwin GC. Mechanisms for impaired effector function in alveolar macrophages from marijuana and cocaine smokers. J Neuroimmunol 2004; 147 (1-2): 82-86
    CrossrefPubMedGoogle Scholar
  • 27 Kagen SL, Kurup VP, Sohnle PG, Fink JN. Marijuana smoking and fungal sensitization. J Allergy Clin Immunol 1983; 71 (04) 389-393
    CrossrefPubMedGoogle Scholar
  • 28 Cescon DW, Page AV, Richardson S, Moore MJ, Boerner S, Gold WL. Invasive pulmonary aspergillosis associated with marijuana use in a man with colorectal cancer. J Clin Oncol 2008; 26 (13) 2214-2215
    CrossrefPubMedGoogle Scholar
  • 29 Benedict K, Thompson III GR, Jackson BR. Cannabis use and fungal infections in a commercially insured population, United States, 2016. Emerg Infect Dis 2020; 26 (06) 1308-1310
    CrossrefPubMedGoogle Scholar
  • 30 Shover CM, Yan P, Jackson NJ. et al. Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis. J Cannabis Res 2022; 4 (01) 46
    CrossrefPubMedGoogle Scholar
  • 31 Quint JJ, Tashkin DP, McKay HS. et al. Marijuana use and pneumonia risk in a cohort of HIV-infected and HIV-uninfected men. Ann Epidemiol 2020; 52: 64-70.e2
    CrossrefPubMedGoogle Scholar
  • 32 Lorenz DR, Uno H, Wolinsky SM, Gabuzda D. Effect of marijuana smoking on pulmonary disease in HIV-infected and uninfected men: a longitudinal cohort study. EClinicalMedicine 2019; 7: 55-64
    CrossrefPubMedGoogle Scholar
  • 33 Waissengrin B, Leshem Y, Taya M. et al. The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: a sigh of relief?. Eur J Cancer 2023; 180: 52-61
    CrossrefPubMedGoogle Scholar
  • 34 Taylor DR, Poulton R, Moffitt TE, Ramankutty P, Sears MR. The respiratory effects of cannabis dependence in young adults. Addiction 2000; 95 (11) 1669-1677
    CrossrefPubMedGoogle Scholar
  • 35 Tan WC, Lo C, Jong A. et al; Vancouver Burden of Obstructive Lung Disease (BOLD) Research Group. Marijuana and chronic obstructive lung disease: a population-based study. CMAJ 2009; 180 (08) 814-820
    CrossrefPubMedGoogle Scholar
  • 36 Moore BA, Augustson EM, Moser RP, Budney AJ. Respiratory effects of marijuana and tobacco use in a U.S. sample. J Gen Intern Med 2005; 20 (01) 33-37
    CrossrefPubMedGoogle Scholar
  • 37 Macleod J, Robertson R, Copeland L, McKenzie J, Elton R, Reid P. Cannabis, tobacco smoking, and lung function: a cross-sectional observational study in a general practice population. Br J Gen Pract 2015; 65 (631) e89-e95
    CrossrefPubMedGoogle Scholar
  • 38 Bloom JW, Kaltenborn WT, Paoletti P, Camilli A, Lebowitz MD. Respiratory effects of non-tobacco cigarettes. Br Med J (Clin Res Ed) 1987; 295 (6612) 1516-1518
    CrossrefPubMedGoogle Scholar
  • 39 Tashkin DP, Coulson AH, Clark VA. et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis 1987; 135 (01) 209-216
    PubMedGoogle Scholar
  • 40 Wenger DS, Triplette M, Shahrir S. et al. Associations of marijuana with markers of chronic lung disease in people living with HIV. HIV Med 2021; 22 (02) 92-101
    CrossrefPubMedGoogle Scholar
  • 41 Hancox RJ, Poulton R, Ely M. et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J 2010; 35 (01) 42-47
    CrossrefPubMedGoogle Scholar
  • 42 Morris MA, Jacobson SR, Kinney GL. et al. Marijuana Use Associations with Pulmonary Symptoms and Function in Tobacco Smokers Enrolled in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS). Chronic Obstr Pulm Dis (Miami) 2018; 5 (01) 46-56
    PubMedGoogle Scholar
  • 43 Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest 1997; 112 (02) 319-326
    CrossrefPubMedGoogle Scholar
  • 44 Vachon L, FitzGerald MX, Solliday NH, Gould IA, Gaensler EA. Single-dose effect of marihuana smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects. N Engl J Med 1973; 288 (19) 985-989
    CrossrefPubMedGoogle Scholar
  • 45 Williams SJ, Hartley JP, Graham JD. Bronchodilator effect of delta1-tetrahydrocannabinol administered by aerosol of asthmatic patients. Thorax 1976; 31 (06) 720-723
    CrossrefPubMedGoogle Scholar
  • 46 Tashkin DP, Reiss S, Shapiro BJ, Calvarese B, Olsen JL, Lodge JW. Bronchial effects of aerosolized delta 9-tetrahydrocannabinol in healthy and asthmatic subjects. Am Rev Respir Dis 1977; 115 (01) 57-65
    PubMedGoogle Scholar
  • 47 Nadel JA, Comroe Jr JH. Acute effects of inhalation of cigarette smoke on airway conductance. J Appl Physiol 1961; 16: 713-716
    CrossrefPubMedGoogle Scholar
  • 48 Tashkin DP, Shapiro BJ, Lee YE, Harper CE. Effects of smoked marijuana in experimentally induced asthma. Am Rev Respir Dis 1975; 112 (03) 377-386
    PubMedGoogle Scholar
  • 49 Gong Jr H, Tashkin DP, Simmons MS, Calvarese B, Shapiro BJ. Acute and subacute bronchial effects of oral cannabinoids. Clin Pharmacol Ther 1984; 35 (01) 26-32
    CrossrefPubMedGoogle Scholar
  • 50 Grassin-Delyle S, Naline E, Buenestado A. et al. Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors. Br J Pharmacol 2014; 171 (11) 2767-2777
    CrossrefPubMedGoogle Scholar
  • 51 Hoffmann D, Raineri R, Hecht SS, Maronpot R, Wynder EL. A study of tobacco carcinogenesis. XIV. Effects of N′-nitrosonornicotine and N′-nitrosonanabasine in rats. J Natl Cancer Inst 1975; 55 (04) 977-981
    CrossrefPubMedGoogle Scholar
  • 52 Aldington S, Williams M, Nowitz M. et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007; 62 (12) 1058-1063
    CrossrefPubMedGoogle Scholar
  • 53 Hancox RJ, Gray AR, Zhang X. et al. Differential effects of cannabis and tobacco on lung function in mid-adult life. Am J Respir Crit Care Med 2022; 205 (10) 1179-1185
    CrossrefPubMedGoogle Scholar
  • 54 Kempker JA, Honig EG, Martin GS. The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study. Ann Am Thorac Soc 2015; 12 (02) 135-141
    CrossrefPubMedGoogle Scholar
  • 55 Najman JM, Bell S, Williams GM. et al. Do tobacco and cannabis use and co-use predict lung function: A longitudinal study. Respir Med 2023; 208: 107124
    CrossrefPubMedGoogle Scholar
  • 56 Papatheodorou SI, Buettner H, Rice MB, Mittleman MA. Recent marijuana use and associations with exhaled nitric oxide and pulmonary function in adults in the United States. Chest 2016; 149 (06) 1428-1435
    CrossrefPubMedGoogle Scholar
  • 57 Aldington S, Harwood M, Cox B. et al; Cannabis and Respiratory Disease Research Group. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J 2008; 31 (02) 280-286
    CrossrefPubMedGoogle Scholar
  • 58 Lazovic-Popovic B, Zlatkovic-Svenda M, Durmic T, Djelic M, Djordjevic Saranovic S, Zugic V. Superior lung capacity in swimmers: some questions, more answers!. Rev Port Pneumol (2006) 2016; 22 (03) 151-156
    PubMedGoogle Scholar
  • 59 Wang RJ, Bhakta NR. The puzzle of marijuana use and forced vital capacity. Ann Am Thorac Soc 2024;2024: In press
    PubMedGoogle Scholar
  • 60 Barjaktarevic I, Cooper CB, Shing T. et al. Effect of marijuana smoking on lung function change in older ever tobacco smokers. Eur Respir J 2022; 60 (03) 2201133
    CrossrefPubMedGoogle Scholar
  • 61 Tashkin DP. Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med 2001; 7 (02) 43-61
    CrossrefPubMedGoogle Scholar
  • 62 Tashkin DP, Simmons MS, Sherrill DL, Coulson AH. Heavy habitual marijuana smoking does not cause an accelerated decline in FEV1 with age. Am J Respir Crit Care Med 1997; 155 (01) 141-148
    CrossrefPubMedGoogle Scholar
  • 63 Taylor DR, Fergusson DM, Milne BJ. et al. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 2002; 97 (08) 1055-1061
    CrossrefPubMedGoogle Scholar
  • 64 Sherrill DL, Krzyzanowski M, Bloom JW, Lebowitz MD. Respiratory effects of non-tobacco cigarettes: a longitudinal study in general population. Int J Epidemiol 1991; 20 (01) 132-137
    CrossrefPubMedGoogle Scholar
  • 65 Pletcher MJ, Vittinghoff E, Kalhan R. et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA 2012; 307 (02) 173-181
    CrossrefPubMedGoogle Scholar
  • 66 Tan WC, Bourbeau J, Aaron SD. et al; CanCOLD Collaborative Research Group, Members of the CanCOLD Collaborative Research Group not listed as authors. The effects of marijuana smoking on lung function in older people. Eur Respir J 2019; 54 (06) 1900826
    CrossrefPubMedGoogle Scholar
  • 67 Hancox RJ, Sears MR. The impact of marijuana smoking on lung function. Eur Respir J 2019; 54 (06) 1902065
    CrossrefPubMedGoogle Scholar
  • 68 Tashkin DP, Roth MD. Impact of marijuana smoking on lung function in older persons. Eur Respir J 2020; 55 (02) 1902328
    CrossrefPubMedGoogle Scholar
  • 69 Roth MD, Arora A, Barsky SH, Kleerup EC, Simmons M, Tashkin DP. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med 1998; 157 (3 Pt 1): 928-937
    CrossrefPubMedGoogle Scholar
  • 70 Tan HS, McAnally HM, Dummer J, Hancox RJ. Lifetime cannabis exposure and small airway function in a population-based cohort study. ERJ Open Res 2022; 8 (02) 00688-2021
    CrossrefPubMedGoogle Scholar
  • 71 Petrache I, Diab K, Knox KS. et al. HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism. Thorax 2008; 63 (05) 463-469
    CrossrefPubMedGoogle Scholar
  • 72 Murtha L, Sathiadoss P, Salameh JP, Mcinnes MDF, Revah G, Chest CT. Chest CT findings in marijuana smokers. Radiology 2023; 307 (01) e212611
    CrossrefPubMedGoogle Scholar
  • 73 Birrer RB, Calderon J. Pneumothorax, pneumomediastinum, and pneumopericardium following Valsalva's maneuver during marijuana smoking. N Y State J Med 1984; 84 (12) 619-620
    PubMedGoogle Scholar
  • 74 Goodyear K, Laws D, Turner J. Bilateral spontaneous pneumothorax in a cannabis smoker. J R Soc Med 2004; 97 (09) 435-436
    CrossrefPubMedGoogle Scholar
  • 75 Hazouard E, Koninck JC, Attucci S, Fauchier-Rolland F, Brunereau L, Diot P. Pneumorachis and pneumomediastinum caused by repeated Müller's maneuvers: complications of marijuana smoking. Ann Emerg Med 2001; 38 (06) 694-697
    CrossrefPubMedGoogle Scholar
  • 76 Herrejón Silvestre A, Blanquer Olivas J, Simo Mompo M, Ruiz Montalt F, Núñez Sánchez C, Chiner Vives E. [Pneumothorax due to drug inhalation]. An Med Interna 1992; 9 (03) 137-139
    PubMedGoogle Scholar
  • 77 Luque III MA, Cavallaro DL, Torres M, Emmanual P, Hillman JV. Pneumomediastinum, pneumothorax, and subcutaneous emphysema after alternate cocaine inhalation and marijuana smoking. Pediatr Emerg Care 1987; 3 (02) 107-109
    CrossrefPubMedGoogle Scholar
  • 78 Beshay M, Kaiser H, Niedhart D, Reymond MA, Schmid RA. Emphysema and secondary pneumothorax in young adults smoking cannabis. Eur J Cardiothorac Surg 2007; 32 (06) 834-838
    CrossrefPubMedGoogle Scholar
  • 79 Hii SW, Tam JD, Thompson BR, Naughton MT. Bullous lung disease due to marijuana. Respirology 2008; 13 (01) 122-127
    CrossrefPubMedGoogle Scholar
  • 80 Johnson MK, Smith RP, Morrison D, Laszlo G, White RJ. Large lung bullae in marijuana smokers. Thorax 2000; 55 (04) 340-342
    CrossrefPubMedGoogle Scholar
  • 81 Phan TD, Lau KK, Li X. Lung bullae and pulmonary fibrosis associated with marijuana smoking. Australas Radiol 2005; 49 (05) 411-414
    CrossrefPubMedGoogle Scholar
  • 82 Tan C, Hatam N, Treasure T. Bullous disease of the lung and cannabis smoking: insufficient evidence for a causative link. J R Soc Med 2006; 99 (02) 77-80
    CrossrefPubMedGoogle Scholar
  • 83 Zhang LR, Morgenstern H, Greenland S. et al; Cannabis and Respiratory Disease Research Group of New Zealand. Cannabis smoking and lung cancer risk: pooled analysis in the International Lung Cancer Consortium. Int J Cancer 2015; 136 (04) 894-903
    CrossrefPubMedGoogle Scholar
  • 84 Callaghan RC, Allebeck P, Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control 2013; 24 (10) 1811-1820
    CrossrefPubMedGoogle Scholar
  • 85 Betser L, Glorion M, Mordant P. et al. Cannabis use and lung cancer: time to stop overlooking the problem?. Eur Respir J 2021; 57 (05) 2004132
    CrossrefPubMedGoogle Scholar
  • 86 Sridhar KS, Raub Jr WA, Weatherby NL. et al. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. J Psychoactive Drugs 1994; 26 (03) 285-288
    CrossrefPubMedGoogle Scholar
  • 87 Krist AH, Davidson KW, Mangione CM. et al; US Preventive Services Task Force. Screening for lung cancer: US preventive services task force recommendation statement. JAMA 2021; 325 (10) 962-970
    CrossrefPubMedGoogle Scholar
  • 88 Blount BC, Karwowski MP, Morel-Espinosa M. et al. Evaluation of bronchoalveolar lavage fluid from patients in an outbreak of e-cigarette, or vaping, product use-associated lung injury—10 states, August-October 2019. MMWR Morb Mortal Wkly Rep 2019; 68 (45) 1040-1041
    CrossrefPubMedGoogle Scholar
  • 89 Butt YM, Smith ML, Tazelaar HD. et al. Pathology of vaping-associated lung injury. N Engl J Med 2019; 381 (18) 1780-1781
    CrossrefPubMedGoogle Scholar
  • 90 www.cdc.gov/EVALI Center for Disease Control and Prevention.
    PubMedGoogle Scholar
  • 91 Tackett AP, Urman R, Barrington-Trimis J. et al. Prospective study of e-cigarette use and respiratory symptoms in adolescents and young adults. Thorax 2023
    PubMedGoogle Scholar
  • 92 Werner-Simon J. Federal Marijuana Rescheduling to a Schedule III Medication Downsides, Cannabis Business Times; May 2024
    PubMed
  • 93 Tashkin DP, Tan WC. Inhaled marijuana and the lung. J Allergy Clin Immunol Pract 2022; 10 (11) 2822-2829
    CrossrefPubMedGoogle Scholar
  • 94 Tashkin DP, Calvarese BM, Simmons MS, Shapiro BJ. Respiratory status of seventy-four habitual marijuana smokers. Chest 1980; 78 (05) 699-706
    CrossrefPubMedGoogle Scholar
  • 95 Tilles DS, Goldenheim PD, Johnson DC, Mendelson JH, Mello NK, Hales CA. Marijuana smoking as cause of reduction in single-breath carbon monoxide diffusing capacity. Am J Med 1986; 80 (04) 601-606
    CrossrefPubMedGoogle Scholar